{
    "clinical_study": {
        "@rank": "35282", 
        "arm_group": [
            {
                "arm_group_label": "Ilaprazole or Pantoprazole placebo", 
                "arm_group_type": "Experimental", 
                "description": "Ilaprazole 10mg, Pantoprazole 40mg, Amoxicillin 1000mg, Clarithromycin 500mg 2 times/day, PO"
            }, 
            {
                "arm_group_label": "Ilaprazole placebo or Pantoprazole", 
                "arm_group_type": "Active Comparator", 
                "description": "Pantoprazole 40mg, Ilaprazole 10mg, Amoxicillin 1000mg, Clarithromycin 500mg 2 times/day,PO"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate of efficacy and safety as H.pylori eradiation\n      effect between Ilaprazole and Pantoprazole triple therapy for 7 days treatment in Gastric\n      and/or Duodenal ulcer patients with H.pylori positive infection."
        }, 
        "brief_title": "Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": "Peptic Ulcer", 
        "condition_browse": {
            "mesh_term": [
                "Peptic Ulcer", 
                "Ulcer"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study is to evaluate of efficacy and safety as H.pylori eradiation effect between\n      Ilaprazole and Pantoprazole triple therapy for 7 days treatment in Gastric and/or Duodenal\n      ulcer patients with H.pylori positive infection."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 year old \u2264 Male or female < 75 year old\n\n          -  Patients who had endoscopically confirmed Gastric and/or duodenal ulcer and H.pylori\n             infection confirmed by Urea Breath Test\n\n          -  Patients who understand the study conditions\n\n          -  Patients who had been given the explanation about the study, and had provided\n             voluntary written informed consent to participate in the stud\n\n        Exclusion Criteria:\n\n          -  Patients with known allergy or hypersensitivity reaction to the Investigational\n             products\n\n          -  Patients who use the Investigational products\n\n          -  Patients who undergone H.pylori eradication\n\n          -  Patients with abnormal laboratory results, as specified below:\n\n        Total bilirubin, creatinine > 1.5 x upper limit of normal Aspartate transminase, Alanine\n        transminase, Alkaline phosphatase, Blood urea nitrogen > 2 x upper limit of normal\n\n          -  Patients who used Proton Pump Inhibitor agents or antibiotics within the last 2 weeks\n             before the start of the Investigational products\n\n          -  Pregnant women and lactating women\n\n          -  Women of childbearing potential who were not using a medically acceptable method of\n             contraception during the study period.(Menopausal women who did not have a menstrual\n             period for at least 12 months were considered infertile)\n\n          -  Patients with uncontrolled Diabetes mellitus\n\n          -  Patients with uncontrolled Hypertension\n\n          -  Patients with Alcoholics\n\n          -  Patients with a history of malignancy within 5 years prior to the study entry (Day 1)\n             (except for basal cell carcinoma of the skin)\n\n          -  Patients who had undergone a esophageal or gastric surgery\n\n          -  Patients who had a hereditary disorder as galactose intolerance, lactose intolerance,\n             glucose-galactose malabsorption\n\n          -  Patients who had participated in other investigational study within 30 days before\n             the study entry (Day 1)\n\n          -  Patients who, in the investigator's opinion, are not suitable for the study for any\n             other reason"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "74 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "323", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 5, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02084420", 
            "org_study_id": "IY-81149-HB03"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ilaprazole or Pantoprazole placebo", 
                "description": "10mg 2  BID( 2 times / day), before breakfast and dinner", 
                "intervention_name": "Ilaprazole", 
                "intervention_type": "Drug", 
                "other_name": "NOLTEC"
            }, 
            {
                "arm_group_label": "Ilaprazole placebo or Pantoprazole", 
                "description": "40mg, BID(2 times / day), before breakfast and dinner", 
                "intervention_name": "Pantoprazole", 
                "intervention_type": "Drug", 
                "other_name": "PANTOLOC"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Pantoprazole"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "June 2, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Bucheon-si, Gyeonggi-do", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Soonchunhang University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Busan", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Pusan National University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Busan", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Inje Busan Paik Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Daegu", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Kyungpook National University Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Daegu", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Yeungnam University Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Daejeon", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Konyang University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Incheon city", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Gachon University Gill Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jeollabuk-do", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Wonkwang University of Medicine & Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Chung Ang University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Inje University Seoul Paik Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "KyungHee University Medical center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Seoul National University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Ewha Womens University Mokdong Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Seoul Asan hoapital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Severance Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Kangbuk Samsung Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "The Catholic University of Korea, Seoul"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wonju-si, Gangwon-do", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Wonju Severance Christian Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Phase\u2162 Study of A Multicenter, Randomized, Double-blind, Active-controlled to Evaluate of Efficacy /Safety as H. Pylori Eradication Effect Between Ilaprazole/Pantoprazole", 
        "overall_official": {
            "affiliation": "IL-YANG Pharmaceutical Co.LTD", 
            "last_name": "IL YANG PHARM", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "South Korea: Ministry of Food and Drug Safety", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "the rate of H.pylori eradication", 
            "safety_issue": "No", 
            "time_frame": "participants will be followed at 7 weeks (visit 4)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02084420"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "the rate of Gastric and/or Duodenal ulcer curation", 
            "safety_issue": "No", 
            "time_frame": "participants will be followed at  7 weeks (visit 4)"
        }, 
        "source": "Il-Yang Pharm. Co., Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Il-Yang Pharm. Co., Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}